• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

DW Healthcare Partners invests in Vets Plus and Noble Pharma

January 11, 2022
Bob Alaburda, Director of Special Projects

The partnership provides growth capital and management expertise to Vets Plus.

DW Healthcare Partners DWHP, a healthcare-focused private equity firm, announced the completion of its investment in Vets Plus, Inc, and Noble Pharma, LLC. Vets Plus is a full-service developer and manufacturer of nutraceutical solutions for the companion animal and livestock markets. Noble Pharma is an-FDA registered manufacturer of animal health pharmaceuticals.

"Our partnership with DWHP provides the growth capital and management depth to improve our CMO customer relationships, expand our capabilities, accelerate new product commercialization, and scale operations," said Dave Nelson, President and Chief Executive Officer at Vets Plus.

"DWHP brings extensive market knowledge and a heightened level of sophistication to the Company. We are extremely blessed to have a strategic partner who shares our vision of superior customer service and best-in-class quality systems," he added.

Founder and current CEO of Vets Plus, Raj Lall, will pass daily responsibilities to Dave Nelson, who will take over as President and CEO. Raj will remain an owner and continue to serve on the board of directors. Doug Schillinger, Eric Moore, Paul Hays, and Dr Chandralal Weerasignhe will join Lall on the board of directors at Vets Plus.

"We are thrilled to be partnering with Raj Lall, Dave Nelson, Alok Kulshreshtha, and the rest of the team," said Schillinger, Managing Director at DWHP. "They have a proven track record of innovative growth. We look forward to supporting them as the business continues to scale in its traditional nutraceutical market and develops more complex pharmaceuticals at Noble."

Advertisement

"DWHP is the right partner for us going forward to help grow our pharmaceutical presence and gain market share in our nutraceutical business,” said Lall. “I'm excited for the next leg of our journey as I focus on research, product development, and serving on the board. I have complete confidence in Dave Nelson who has led our day-to-day operations as President for the past six years and will lead the Company as CEO."

Reference

DW Healthcare Partners Invests in Vets Plus. PRNewswire. January 10, 2022. Accessed January 11, 2022. https://www.prnewswire.com/news-releases/dw-healthcare-partners-invests-in-vets-plus-301456815.html

Related Content:

Business
CityVet Celina opens in Prosper, Texas
CityVet Celina opens in Prosper, Texas
Animal biomedical device company announces new senior technical services veterinarian
Animal biomedical device company announces new senior technical services veterinarian
Four ways to curb no shows
Four ways to curb no shows

Advertisement

Latest News

Can our Pride panel answer these LGBTQ+ trivia questions?

Creating inclusive spaces for the LGBTQ+ community in vet med

Happy Pride Month, Hill's launches Prescription Diet ONC Care, and more

CityVet Celina opens in Prosper, Texas

View More Latest News
Advertisement